These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12549957)

  • 1. Nesiritide: a novel approach for acute heart failure.
    Vichiendilokkul A; Tran A; Racine E
    Ann Pharmacother; 2003 Feb; 37(2):247-58. PubMed ID: 12549957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nesiritide: a review of its use in acute decompensated heart failure.
    Keating GM; Goa KL
    Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of nesiritide for the treatment of decompensated heart failure.
    Emerman CL
    Rev Cardiovasc Med; 2002; 3 Suppl 4():S28-34. PubMed ID: 12439428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.
    Sackner-Bernstein JD; Kowalski M; Fox M; Aaronson K
    JAMA; 2005 Apr; 293(15):1900-5. PubMed ID: 15840865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nesiritide for the treatment of congestive heart failure.
    Iyengar S; Feldman DS; Trupp R; Abraham WT
    Expert Opin Pharmacother; 2004 Apr; 5(4):901-7. PubMed ID: 15102572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nesiritide: a new drug for the treatment of decompensated heart failure.
    Elkayam U; Akhter MW; Tummala P; Khan S; Singh H
    J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):181-94. PubMed ID: 12232567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.
    Yancy CW
    Drug Saf; 2007; 30(9):765-81. PubMed ID: 17722969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
    Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U;
    Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.
    Abraham WT; Cheng ML; Smoluk G;
    Congest Heart Fail; 2005; 11(2):59-64. PubMed ID: 15860969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nesiritide, a novel treatment for heart failure].
    Francisco-Méndez G
    Rev Med Inst Mex Seguro Soc; 2007; 45(3):281-9. PubMed ID: 17692167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
    DeWald TA; Hernandez AF
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nesiritide: a new therapy for the treatment of heart failure.
    Maisel AS
    Cardiovasc Toxicol; 2003; 3(1):37-42. PubMed ID: 12668889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "BNP" for heart failure: role of nesiritide in cardiovascular therapeutics.
    Mills RM; Hobbs RE; Young JB
    Congest Heart Fail; 2002; 8(5):270-3. PubMed ID: 12368590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nesiritide: harmful or harmless?
    Dorsch MP; Rodgers JE
    Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nesiritide: trials and tribulations.
    Arora RR
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):165-9. PubMed ID: 17056828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nesiritide: review of clinical pharmacology and role in heart failure management.
    Cheng JW
    Heart Dis; 2002; 4(3):199-203. PubMed ID: 12028606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D; Burger AJ
    Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesiritide: practical guide to its safe and effective use.
    Fonarow GC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S32-5. PubMed ID: 12439360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short and long-term mortality with nesiritide.
    Arora RR; Venkatesh PK; Molnar J
    Am Heart J; 2006 Dec; 152(6):1084-90. PubMed ID: 17161057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.